Current approaches in regenerative medicine for the treatment of diabetes: introducing CRISPR/CAS9 technology and the case for non-embryonic stem cell therapy

Keywords: Stem cell therapy, type 1 diabetes, beta cells, adult stem cells, induced pluripotent stem cells

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text